Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 24

Trial Status

Completed5
Terminated2

Role Distribution

Principal Investigator5
Other Roles2
PI Rate71%

Activity Timeline

Clinical Trials (7)

NCT00602693Phase 1Completed
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
LeukemiaLymphomaMultiple Myeloma+2 more
PrincipalinvestigatorStart date: 2007-07-23
NCT00309842Phase 2Completed
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+10 more
StudychairStart date: 2005-07-28
NCT00305682Phase 2Completed
Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
PrincipalinvestigatorStart date: 2005-06-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Margaret L. MacMillan, MD

Masonic Cancer Center, University of Minnesota

Very Similar
4 trials

Shared therapeutic areas:

LeukemiaLymphomaMyelodysplastic Syndromes+4 more

Worked with same sponsors:

Masonic Cancer Center, University of Minnesota
Collaborated on 1 trial
Similarity Score74%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemiaLymphoma+8 more

Worked with same sponsors:

National Cancer Institute (NCI)National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score16%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+7 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score14%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+3 more
Similarity Score9%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteGraft vs Host DiseaseLymphoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinBreast CancerCancer of Kidney+2 more
Similarity Score7%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score6%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerCancer of KidneyMultiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLeukemiaLymphoma, Non-Hodgkin

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT00602693Phase 1PrincipalInvestigator

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

LeukemiaLymphomaMultiple Myeloma+2 more
Completed
NCT00309842Phase 2StudyChair

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+10 more
Completed
NCT00305682Phase 2PrincipalInvestigator

Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Completed
NCT00290641Not ApplicablePrincipalInvestigator

Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer

Chronic Myeloproliferative DisordersLeukemiaLymphoma+1 more
Completed
NCT00365287Phase 1/2StudyChair

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Breast CancerKidney CancerLeukemia+3 more
Completed
NCT00376519Phase 1PrincipalInvestigator

Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases

Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Terminated
NCT00963872Phase 1/2PrincipalInvestigator

Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer

LeukemiaLymphomaMultiple Myeloma+1 more
Terminated

All 7 trials loaded